Incidence of retinopathy of prematurity treatment in extremely preterm infants in China
- PMID: 34467552
- DOI: 10.1111/ppe.12810
Incidence of retinopathy of prematurity treatment in extremely preterm infants in China
Abstract
Background: Retinopathy of prematurity (ROP) continues to be a major cause of visual impairment and blindness in premature infants and children.
Objectives: To investigate the incidence of severe ROP receiving treatment in extremely preterm (EP) infants in China over time. The risk factors for ROP treatment were also assessed.
Methods: This was a multicentre retrospective study and a subanalysis of baseline data from the "Outcomes of EP infants in China 2010-2019" study. This study was conducted in 68 tertiary neonatal care centres from 31 provinces of China. Infants with a gestational age of 230 -276 weeks and admitted to a neonatal unit within the first 72 h of life between 2010 and 2019 were enrolled. Incidence of ROP was analysed in infants who survived to 32 weeks postmenstrual age and screened for ROP. Multivariable modified Poisson regression models were used to identify risk factors for ROP treatment.
Results: Among 7295 eligible infants, 4701 (64.5%) survived to 32 weeks postmenstrual age and met ROP screening criteria. Of the 3756 infants who screened and with ROP data, 2320 (61.8%) developed ROP of any stage. The overall incidence of ROP treatment was 12.6%, decreasing from 45.5% at 23 weeks to 8.3% at 27 weeks. During the 10-year period, the incidence of ROP treatment did not change, although the incidence of any ROP increased over time. Independent risk factors associated with ROP treatment included lower gestational age, small for gestational age, multiple birth, severe intraventricular haemorrhage, patent ductus arteriosus and supplemental oxygen duration.
Conclusions: The incidence of EP infants receiving ROP treatment showed no change during this 10-year period in China. Prevention of prematurity and foetal growth restriction, judicious use of oxygen and reducing comorbidities are promising factors that may reduce the incidence of ROP needing treatment in these high-risk infants.
Keywords: extremely premature; incidence; infant; retinopathy of prematurity; risk factors.
© 2021 John Wiley & Sons Ltd.
References
REFERENCES
-
- Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618-637.
-
- Hellgren KM, Tornqvist K, Jakobsson PG, et al. Ophthalmologic outcome of extremely preterm infants at 6.5 years of age: Extremely Preterm Infants in Sweden Study (EXPRESS). JAMA Ophthalmol. 2016;134:555-562.
-
- Molloy CS, Anderson PJ, Anderson VA, Doyle LW. The long-term outcome of extremely preterm (<28 Weeks’ gestational age) infants with and without severe retinopathy of prematurity. J Neuropsychol. 2016;10:276-294.
-
- Glass TJA, Chau V, Gardiner J, et al. Severe retinopathy of prematurity predicts delayed white matter maturation and poorer neurodevelopment. Arch Dis Child Fetal Neonatal Ed. 2017;102:532-537.
-
- Zhu Z, Yuan L, Wang J, et al. Mortality and morbidity of infants born extremely preterm at tertiary medical centers in China from 2010 to 2019. JAMA Network Open. 2021;4:e219382.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
